# Transcranial Electrical Neuromodulation for Suppressing Epileptiform Discharges

> **NCT02516228** · NA · TERMINATED · sponsor: **Electrical Geodesics, Inc.** · enrollment: 6 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DEVICE:** GTEN 100

## Key facts

- **NCT ID:** NCT02516228
- **Lead sponsor:** Electrical Geodesics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-08
- **Primary completion:** 2018-05
- **Final completion:** 2018-05
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Business decision to discontinue development of this investigational device
- **Last updated:** 2020-07-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02516228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02516228, "Transcranial Electrical Neuromodulation for Suppressing Epileptiform Discharges". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02516228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*